SPBC1348.07 Antibody

What is SPBC1348.07 and why is it important in S. pombe research?

SPBC1348.07 is a protein-coding gene in Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. The protein has been identified with UniProt accession number Q9P3V3. Studying this protein is important for understanding fundamental cellular processes in S. pombe, which serves as a model organism for eukaryotic molecular biology research. Antibodies against this protein enable researchers to investigate its expression, localization, and function in various cellular contexts and genetic backgrounds. The study of S. pombe proteins through specific antibodies contributes to our understanding of conserved cellular mechanisms across eukaryotes .

What experimental applications is the SPBC1348.07 antibody suitable for?

Based on similar monoclonal antibodies in research, the SPBC1348.07 antibody would likely be suitable for multiple experimental applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The specific applications would need to be validated by the researcher as is standard practice with antibodies in molecular biology research. For optimal results in each application, appropriate controls should be included to confirm specificity and sensitivity of detection .

How should I design validation experiments for this antibody?

When validating the SPBC1348.07 antibody, implement a multi-step approach:

• Western blot analysis using wild-type S. pombe lysates alongside a negative control (such as a SPBC1348.07 deletion strain if available)

• Immunofluorescence comparing staining patterns in wild-type and deletion/knockdown strains

• Blocking peptide competition assay to confirm specificity

• Cross-reactivity testing with related proteins if known

The validation should include appropriate positive and negative controls. Documentation of specificity is crucial before proceeding with experimental applications. Consider using the antibody in combination with genetic approaches (gene tagging, deletion) to confirm results through multiple methodologies .

What are the recommended storage and handling procedures?

To maintain antibody integrity and performance:

• Store the antibody at -20°C for long-term storage

• For working solutions, store at 4°C for up to two weeks

• Avoid repeated freeze-thaw cycles by preparing small aliquots

• When handling, maintain cold chain and use sterile technique

• Prior to use, centrifuge the antibody vial briefly to collect the solution at the bottom

• For dilutions, use high-quality buffers with appropriate preservatives

Improper storage and handling can lead to degradation and reduced activity, compromising experimental results. Maintaining detailed records of freezing/thawing and dilution preparations helps monitor antibody performance over time .

How can I optimize the SPBC1348.07 antibody for chromatin immunoprecipitation (ChIP) experiments?

Optimizing the SPBC1348.07 antibody for ChIP experiments requires methodical adjustment of several parameters:

• Crosslinking optimization: Test both formaldehyde concentrations (0.5-3%) and crosslinking times (5-20 minutes) to preserve protein-DNA interactions without over-fixation

• Sonication parameters: Evaluate different power settings and cycle numbers to achieve 200-500bp DNA fragments

• Antibody titration: Test a range of antibody amounts (2-10μg per reaction) to determine the optimal signal-to-noise ratio

• Incubation conditions: Compare overnight incubation at 4°C with shorter incubations (4-6 hours)

• Washing stringency: Adjust salt concentrations in wash buffers to minimize background while maintaining specific signals

Each step should be systematically optimized with appropriate controls, including input samples, IgG controls, and positive control antibodies against well-characterized proteins (e.g., histones). For S. pombe-specific ChIP protocols, adaptation of existing methods used with similar antibodies targeting nuclear proteins can serve as a starting point .

What approaches can resolve inconsistent detection results between experiments?

When encountering inconsistent detection results, implement a systematic troubleshooting approach:

• Antibody validation verification: Confirm antibody specificity using knockout/knockdown controls

• Protein expression variability: Analyze cell cycle dependency or stress-induced changes in expression

• Epitope accessibility issues: Test different sample preparation methods that may affect protein conformation

• Technical variables: Standardize lysate preparation, protein quantification, and loading

• Detection system sensitivity: Compare different development methods (ECL vs. fluorescence)

Create a structured experimental matrix to isolate variables one at a time. Document all experimental conditions meticulously, including reagent lot numbers, incubation times/temperatures, and equipment settings. This systematic approach allows identification of critical variables affecting antibody performance across experiments .

How can the SPBC1348.07 antibody be integrated into multi-omics experimental designs?

Integrating the SPBC1348.07 antibody into multi-omics experimental designs requires careful planning:

• Parallel sample processing: Design experiments where the same cell population is divided for antibody-based detection and other omics approaches (RNA-seq, proteomics)

• Sequential analyses: Perform ChIP-seq using the antibody followed by RNA-seq to correlate binding sites with transcriptional outcomes

• Comparative approaches: Use the antibody for protein detection in wild-type vs. mutant strains that have been characterized by genomic or proteomic analyses

• Time-course experiments: Combine antibody-based detection with temporal omics analyses to track dynamic changes

This integration requires careful experimental design to maintain sample comparability across different analytical platforms. Computational analysis pipelines should be established beforehand to facilitate data integration and correlation analysis across the different data types .

What controls are essential when using SPBC1348.07 antibody in immunofluorescence studies?

When conducting immunofluorescence studies with the SPBC1348.07 antibody, implement these essential controls:

• Primary antibody specificity control: Include a deletion strain or RNAi-mediated knockdown of SPBC1348.07

• Secondary antibody background control: Omit primary antibody but include all other steps

• Peptide competition control: Pre-incubate antibody with blocking peptide before application

• Autofluorescence control: Process cells without any antibodies to assess natural fluorescence

• Positive control: Include detection of a known protein with established localization pattern

• Colocalization control: When applicable, co-stain with markers of subcellular compartments

Additionally, optimize fixation methods (formaldehyde, methanol, or combined approaches) as these can significantly affect epitope accessibility and staining patterns. Document all microscope settings consistently between experiments to enable quantitative comparisons .

How should I approach quantitative analysis of Western blot data using this antibody?

For rigorous quantitative analysis of Western blot data using the SPBC1348.07 antibody:

• Experimental standardization:

  • Maintain consistent protein loading (validated by total protein staining)

  • Use internal loading controls appropriate for your experimental conditions

  • Perform technical replicates (minimum triplicate) and biological replicates (minimum n=3)

• Signal acquisition:

  • Use a digital image capture system with a linear dynamic range

  • Avoid saturation of signals (perform exposure series)

  • Capture raw image files before any adjustment

• Quantification methodology:

  • Normalize target protein signals to loading controls or total protein

  • Use appropriate software (ImageJ, Image Lab, etc.) with consistent analysis parameters

  • Apply statistical analysis appropriate for your experimental design

• Data presentation:

  • Present both representative images and quantification graphs

  • Include all statistical parameters (n, mean, SD/SEM, p-values)

  • Clearly state normalization methods and software used

This approach ensures reproducibility and statistical validity of quantitative Western blot analyses using the SPBC1348.07 antibody .

What strategies can improve signal-to-noise ratio in immunoprecipitation experiments?

To improve signal-to-noise ratio in immunoprecipitation experiments with the SPBC1348.07 antibody:

• Pre-clearing optimization:

  • Extend pre-clearing time (2-4 hours or overnight)

  • Use species-matched pre-immune serum or IgG

  • Add 1-5% BSA to blocking buffer

• Antibody binding conditions:

  • Test different antibody amounts (1-10μg per reaction)

  • Optimize antibody incubation time (4 hours to overnight)

  • Compare direct vs. indirect capture methods

• Wash stringency adjustment:

  • Implement a gradient of increasing salt concentrations (150-500mM)

  • Add low concentrations of non-ionic detergents (0.1-0.5% NP-40 or Triton X-100)

  • Increase number of washes (4-6 times)

• Elution method comparison:

  • Compare harsh (boiling in SDS buffer) vs. mild (peptide competition) elution

  • Test native elution conditions if protein activity needs to be preserved

Document each optimization step systematically to identify the critical parameters affecting background reduction while maintaining specific signal detection .

How can I address cross-reactivity issues with the SPBC1348.07 antibody?

When addressing potential cross-reactivity issues with the SPBC1348.07 antibody:

• Computational analysis:

  • Perform sequence alignment of the immunogen against the entire S. pombe proteome

  • Identify proteins with similar epitopes that might cross-react

• Experimental validation:

  • Test antibody reactivity using deletion mutants and overexpression constructs

  • Perform peptide competition assays with varying concentrations of blocking peptide

  • Use orthogonal detection methods (e.g., mass spectrometry) to identify all proteins pulled down

• Specificity enhancement:

  • Implement more stringent washing conditions

  • Consider antibody affinity purification using immobilized antigen

  • Use two-step detection systems (e.g., sequential immunoprecipitations)

• Result interpretation:

  • Always include controls for specificity in each experiment

  • Acknowledge any confirmed cross-reactivity in your data interpretation

  • Validate key findings with alternative methods

This systematic approach helps identify and mitigate cross-reactivity issues, ensuring reliable experimental results even with imperfectly specific antibodies .

What is the recommended approach for multiplexing SPBC1348.07 antibody with other antibodies?

For successful multiplexing of the SPBC1348.07 antibody with other antibodies:

• Antibody compatibility assessment:

  • Verify host species and isotype of all antibodies to avoid cross-reactivity

  • Test spectral compatibility of fluorophores or enzyme conjugates

  • Validate each antibody individually before combining

• Sequential vs. simultaneous protocols:

  • For western blotting: Compare sequential probing (with stripping) to simultaneous incubation

  • For immunofluorescence: Test sequential antibody application vs. cocktail approach

  • For flow cytometry: Optimize compensation settings for spectral overlap

• Buffer compatibility:

  • Test different blocking reagents (BSA, milk, serum) for optimal performance with all antibodies

  • Adjust detergent concentrations to maintain all epitopes' accessibility

  • Optimize incubation times and temperatures for all antibodies

• Controls for multiplexed detection:

  • Include single-antibody controls alongside multiplexed samples

  • Perform antibody omission controls to verify signal specificity

  • Include samples with known expression patterns for each target

This methodical approach ensures reliable simultaneous detection of multiple targets including SPBC1348.07 protein .

How should I analyze SPBC1348.07 expression across different cell cycle stages?

To analyze SPBC1348.07 expression across different cell cycle stages:

• Synchronization methods comparison:

  • Evaluate different synchronization techniques (temperature-sensitive cdc mutants, nitrogen starvation/release, elutriation)

  • Validate synchronization efficiency using established cell cycle markers

  • Consider potential artifacts introduced by synchronization methods

• Sampling strategy:

  • Collect samples at regular intervals (every 10-15 minutes) following synchronization

  • Prepare parallel samples for cell cycle stage verification (FACS, septation index)

  • Preserve samples appropriately for multiple analyses (protein, RNA, microscopy)

• Quantitative analysis:

  • Normalize SPBC1348.07 protein levels to appropriate reference proteins or total protein

  • Plot expression values against cell cycle progression markers

  • Apply statistical analysis for cyclical data when appropriate

• Integrative analysis:

  • Compare protein levels with mRNA expression when possible

  • Correlate with post-translational modifications if detected

  • Compare with published datasets of cell cycle-regulated genes in S. pombe

This comprehensive approach enables robust analysis of cell cycle-dependent regulation of SPBC1348.07 expression, distinguishing genuine periodicity from technical artifacts .

What bioinformatic tools are recommended for analyzing ChIP-seq data generated using this antibody?

For analyzing ChIP-seq data generated using the SPBC1348.07 antibody:

• Pre-processing and quality control:

  • FastQC for raw sequence quality assessment

  • Cutadapt or Trimmomatic for adapter removal and quality trimming

  • Bowtie2 or BWA for alignment to the S. pombe genome

• Peak calling and annotation:

  • MACS2 with parameters optimized for transcription factors or chromatin modifiers

  • Homer for motif discovery and annotation

  • BEDTools for genomic feature intersection

• Visualization platforms:

  • IGV or JBrowse for genome browser visualization

  • DeepTools for heatmap and profile plot generation

  • Circos for circular genome visualization of binding sites

• Integrative analysis:

  • ChIPseeker for comprehensive annotation and visualization

  • DiffBind for differential binding analysis between conditions

  • ChIP-Atlas for comparison with published datasets

  • Integration with RNA-seq using tools like BETA or ChIP-Enrich

• S. pombe-specific resources:

  • PomBase for genome annotation and functional information

  • Utilize S. pombe-specific genome builds and gene annotations

This analytical pipeline provides comprehensive characterization of binding sites, associated sequence motifs, and potential regulatory functions of the SPBC1348.07 protein .

How does SPBC1348.07 antibody performance compare with other S. pombe protein antibodies?

When evaluating SPBC1348.07 antibody performance relative to other S. pombe protein antibodies:

• Specificity comparison:

  • Assess background levels in negative controls (deletion strains)

  • Compare cross-reactivity profiles in western blot applications

  • Evaluate non-specific binding in immunoprecipitation experiments

• Sensitivity assessment:

  • Compare detection limits using dilution series of recombinant proteins

  • Evaluate ability to detect endogenous protein at physiological levels

  • Test performance across different experimental conditions

• Application versatility:

  • Compare performance across multiple techniques (WB, IP, IF, ChIP)

  • Assess buffer compatibility and protocol flexibility

  • Evaluate stability and lot-to-lot consistency

• Quantitative benchmarking:

  • Signal-to-noise ratio measurements

  • Reproducibility across technical and biological replicates

  • Dynamic range of detection

This comparative analysis helps researchers select the most appropriate antibodies for their specific experimental requirements and interpret results in context of antibody performance characteristics .

What are the current research directions utilizing SPBC1348.07 antibody in S. pombe studies?

Current research utilizing antibodies against S. pombe proteins like SPBC1348.07 spans several areas:

• Chromatin regulation studies:

  • Investigation of protein interactions with chromatin remodeling complexes

  • Analysis of binding patterns at centromeres, telomeres, or specific gene loci

  • Examination of relationships with heterochromatin formation

• Cell cycle regulation:

  • Characterization of expression and localization changes throughout cell division

  • Investigation of potential roles in checkpoint regulation

  • Analysis of interactions with core cell cycle machinery

• Stress response mechanisms:

  • Examination of protein behavior under various stress conditions

  • Analysis of translocation or modification in response to environmental changes

  • Identification of stress-specific interaction partners

• Comparative genomics applications:

  • Studies of conservation with homologous proteins in other organisms

  • Investigation of divergent functions between related proteins

  • Evolutionary analysis of protein structure and function

Understanding these research contexts helps researchers position their own work within the field and identify potential collaborations or novel applications for the SPBC1348.07 antibody .

How can the SPBC1348.07 antibody be used in proximity ligation assays?

To implement proximity ligation assays (PLA) using the SPBC1348.07 antibody:

• Experimental design considerations:

  • Select secondary antibodies with appropriate species specificity

  • Choose a complementary antibody against a suspected interaction partner

  • Design proper controls (single antibody, non-interacting protein pairs)

• Protocol optimization:

  • Adjust fixation methods to preserve protein-protein interactions

  • Optimize antibody dilutions specifically for PLA (typically higher concentrations)

  • Determine optimal incubation times and temperatures

• Signal detection and analysis:

  • Use confocal microscopy for precise localization of interaction signals

  • Implement automated image analysis for quantification of PLA dots

  • Compare signal distribution with individual protein localizations

• Validation approaches:

  • Confirm interactions using orthogonal methods (co-IP, FRET)

  • Test interaction disruption through mutations or condition changes

  • Use protein-fragment complementation as a complementary approach

This technique enables visualization and quantification of endogenous protein interactions in their native cellular context, providing spatial information about SPBC1348.07 protein interactions .

What considerations are important when using the antibody for super-resolution microscopy?

When employing the SPBC1348.07 antibody for super-resolution microscopy:

• Sample preparation optimization:

  • Test different fixation protocols (paraformaldehyde, methanol, glyoxal)

  • Evaluate permeabilization methods for optimal antibody penetration

  • Consider using smaller detection probes (Fab fragments, nanobodies)

• Labeling strategy selection:

  • For STORM/PALM: Use photoswitchable fluorophores (Alexa 647, mEos)

  • For STED: Select fluorophores with high depletion efficiency (ATTO dyes)

  • For SIM: Choose bright, photostable fluorophores (Alexa 488, 568)

• Technical considerations:

  • Implement drift correction strategies (fiducial markers)

  • Optimize buffer conditions for specific super-resolution techniques

  • Adjust labeling density for optimal resolution

• Validation approaches:

  • Compare with conventional microscopy to identify potential artifacts

  • Perform imaging controls to assess background and non-specific binding

  • Validate structures with orthogonal high-resolution techniques

• Analysis considerations:

  • Implement appropriate reconstruction algorithms

  • Apply cluster analysis for quantification

  • Consider multicolor registration for colocalization studies

Super-resolution microscopy with the SPBC1348.07 antibody can reveal detailed subcellular localization patterns not visible with conventional microscopy, providing insights into protein organization at the nanoscale level .

How should I modify protocols when studying SPBC1348.07 in different genetic backgrounds?

When studying SPBC1348.07 across different genetic backgrounds:

• Lysate preparation adaptations:

  • Adjust lysis conditions for strains with different cell wall properties

  • Optimize extraction protocols for mutants affecting protein expression

  • Consider strain-specific protease inhibitor requirements

• Detection parameter adjustments:

  • Calibrate antibody concentrations based on expression levels in each strain

  • Modify exposure times or detection sensitivity accordingly

  • Consider differential loading to compensate for expression variations

• Control implementation:

  • Include wild-type controls in every experiment

  • Use spiked-in standards for quantitative comparisons

  • Employ tagged versions in parallel when possible

• Interpretation considerations:

  • Account for genetic interactions affecting SPBC1348.07 expression

  • Consider epistatic relationships when interpreting results

  • Document strain-specific antibody performance variations

These adaptations ensure reliable detection and accurate comparison of SPBC1348.07 across different genetic backgrounds, enabling robust genetic interaction studies .

What are the best practices for studying post-translational modifications of SPBC1348.07?

For studying post-translational modifications (PTMs) of SPBC1348.07:

• Sample preparation optimization:

  • Include phosphatase inhibitors for phosphorylation studies

  • Add deubiquitinase inhibitors for ubiquitination analysis

  • Consider rapid lysis methods to preserve labile modifications

• Enrichment strategies:

  • Implement immunoprecipitation with the SPBC1348.07 antibody prior to PTM detection

  • Consider PTM-specific enrichment (phosphopeptide enrichment, ubiquitin remnant motif antibodies)

  • Use tandem purification approaches for challenging modifications

• Detection methods:

  • Employ Phos-tag gels for mobility shift detection of phosphorylation

  • Use modification-specific antibodies in Western blotting

  • Implement mass spectrometry for comprehensive PTM mapping

• Functional validation:

  • Generate phosphomimetic and phospho-null mutations

  • Compare PTM patterns under different cellular conditions

  • Correlate modifications with protein function using genetic approaches

This comprehensive approach enables characterization of PTMs affecting SPBC1348.07 function, localization, or stability, providing insights into its regulation under different cellular conditions .